IUHSA
RIGL icon

Itau Unibanco Holding S.A.’s Rigel Pharmaceuticals RIGL Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-189
Closed -$5K – 963
2019
Q3 		$5K Hold
189
– – ﹤0.01% 293
2019
Q2 		$5K Sell
189
-149
-44% -$3.36K ﹤0.01% 596
2019
Q1 		$8K Hold
338
– – ﹤0.01% 578
2018
Q4 		$8K Sell
338
-26
-7% -$734 ﹤0.01% 578
2018
Q3 		$12K Sell
364
-14
-4% -$420 ﹤0.01% 579
2018
Q2 		$11K Hold
378
– – ﹤0.01% 698
2018
Q1 		$13K Buy
378
+253
+202% +$10.1K ﹤0.01% 553
2017
Q4 		$5K Buy
+125
New +$4.76K ﹤0.01% 531

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Itau Unibanco Holding S.A.'s RIGL Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of Rigel Pharmaceuticals (RIGL) in Q4 2019, closing a stake of 189 shares — an estimated $5K sold.

Itau Unibanco Holding S.A. first reported a position in RIGL in Q4 2017 and held it in 8 quarters. The position peaked at $13K in Q1 2018. 136 funds tracked by Wall St. Rank hold RIGL as of Q4 2019.

  • Itau Unibanco Holding S.A. reported no remaining Rigel Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 189 Rigel Pharmaceuticals shares in Q4 2019, an estimated $5K.
  • Itau Unibanco Holding S.A. first reported a position in Rigel Pharmaceuticals in Q4 2017 and held it in 8 quarters.
  • Itau Unibanco Holding S.A.'s Rigel Pharmaceuticals position peaked at $13K in Q1 2018.
  • 136 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.